Biologics development represents a rapidly expanding segment of the biopharmaceutical industry, focused on creating complex, high-value therapies derived from living organisms. This dynamic field encompasses monoclonal antibodies, recombinant proteins, biosimilars, vaccines, cell therapies, and gene therapies. The biologics development process requires a multidisciplinary approach tha... https://www.kemwellbiopharma.com/biologics-development/